ARCT
|
Arcturus Therapeutics Ltd.
|
1.81%
|
US
|
NASDAQ
|
FATE
|
Fate Therapeutics, Inc.
|
1.68%
|
US
|
NASDAQ
|
TXG
|
10x Genomics, Inc.
|
1.65%
|
US
|
NASDAQ
|
MASS
|
908 Devices Inc.
|
1.49%
|
US
|
NASDAQ
|
MRNA
|
Moderna, Inc.
|
1.43%
|
US
|
NASDAQ
|
NVDA
|
NVIDIA Corporation
|
1.35%
|
US
|
NASDAQ
|
PFE
|
Pfizer, Inc.
|
1.33%
|
US
|
NYSE
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
1.30%
|
US
|
NASDAQ
|
BFLY
|
Butterfly Network, Inc.
|
1.30%
|
US
|
NYSE
|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
1.26%
|
US
|
NASDAQ
|
NRIX
|
Nurix Therapeutics, Inc.
|
1.16%
|
US
|
NASDAQ
|
QSI
|
Quantum-Si
|
1.15%
|
US
|
NASDAQ
|
CDXS
|
Codexis, Inc.
|
0.97%
|
US
|
NASDAQ
|
ATAI
|
ATAI Life Sciences N.V.
|
0.80%
|
US
|
NASDAQ
|
CERS
|
Cerus Corporation
|
0.72%
|
US
|
NASDAQ
|
GH
|
Guardant Health, Inc.
|
0.72%
|
US
|
NASDAQ
|
PSNL
|
Personalis, Inc.
|
0.58%
|
US
|
NASDAQ
|
CMPS
|
COMPASS Pathways Plc
|
0.52%
|
US
|
NASDAQ
|
NVTA
|
Invitae Corporation
|
0.50%
|
US
|
NYSE
|
BLI
|
Berkeley Lights, Inc.
|
0.39%
|
US
|
NASDAQ
|